These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15821649)

  • 1. Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide.
    Filosso PL; Ruffini E; Oliaro A; Rena O; Casadio C; Mancuso M; Turello D; Cristofori RC; Maggi G
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):819-24. PubMed ID: 15821649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases.
    Veronesi G; Morandi U; Alloisio M; Terzi A; Cardillo G; Filosso P; Rea F; Facciolo F; Pelosi G; Gandini S; Calabrò F; Casali C; Marulli G; Spaggiari L
    Lung Cancer; 2006 Jul; 53(1):111-5. PubMed ID: 16697073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.
    Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW
    Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Takiguchi Y; Sekine Y; Shibuya K; Iizasa T; Kimura H; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Nov; 82(5):1802-7. PubMed ID: 17062251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
    Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
    Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current outcome in patients with lung cancer and positive mediastinoscopy.
    Rooker S; Van Schil P; Van den Brande F; De Maeseneer M
    Acta Chir Belg; 2001; 101(6):273-6. PubMed ID: 11868502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
    Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
    Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease--results from a review of 82 consecutive cases diagnosed between 1992 and 2004.
    Jabbour J; Cumming R; Scolyer RA; Hruby G; Thompson JF; Lee S
    Ann Surg Oncol; 2007 Jun; 14(6):1943-52. PubMed ID: 17356954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Large cell neuroendocrine carcinoma of the lung].
    Mimae T; Yamashita M; Maeda A; Toyosaki R; Suehisa H; Komori E; Sawada S; Kurita A; Takashima S
    Kyobu Geka; 2009 Jun; 62(6):442-5. PubMed ID: 19522201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
    Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge.
    Bermúdez A; Vighi S; García A; Sardi J
    Gynecol Oncol; 2001 Jul; 82(1):32-9. PubMed ID: 11426959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
    Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
    Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.